Stock Scorecard
Stock Summary for Edwards Lifesciences Corp (EW) - $88.16 as of 6/2/2026 11:03:58 AM EST
Total Score
13 out of 30
Safety Score
61 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for EW
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for EW
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for EW
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for EW
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for EW (61 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 6 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 2 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for EW
Financial Details for EW
Company Overview |
|
|---|---|
| Ticker | EW |
| Company Name | Edwards Lifesciences Corp |
| Country | USA |
| Description | Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 88.16 |
| Price 4 Years Ago | 74.61 |
| Last Day Price Updated | 6/2/2026 11:03:58 AM EST |
| Last Day Volume | 7,649,919 |
| Average Daily Volume | 5,402,099 |
| 52-Week High | 89.14 |
| 52-Week Low | 72.30 |
| Last Price to 52 Week Low | 21.94% |
Valuation Measures |
|
| Trailing PE | 47.65 |
| Industry PE | 101.78 |
| Sector PE | 59.49 |
| 5-Year Average PE | 44.94 |
| Free Cash Flow Ratio | 20.74 |
| Industry Free Cash Flow Ratio | 31.00 |
| Sector Free Cash Flow Ratio | 25.42 |
| Current Ratio Most Recent Quarter | 4.42 |
| Total Cash Per Share | 4.25 |
| Book Value Per Share Most Recent Quarter | 17.90 |
| Price to Book Ratio | 4.82 |
| Industry Price to Book Ratio | 8.73 |
| Sector Price to Book Ratio | 9.57 |
| Price to Sales Ratio Twelve Trailing Months | 8.05 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.36 |
| Sector Price to Sales Ratio Twelve Trailing Months | 9.36 |
| Analyst Buy Ratings | 17 |
| Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
| Total Shares Outstanding | 575,800,000 |
| Market Capitalization | 50,762,528,000 |
| Institutional Ownership | 94.06% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 2.23% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 8.20% |
| Annual Earnings Growth | -74.28% |
| Reported EPS 12 Trailing Months | 1.85 |
| Reported EPS Past Year | 0.78 |
| Reported EPS Prior Year | 2.56 |
| Net Income Twelve Trailing Months | 1,092,800,000 |
| Net Income Past Year | 1,073,500,000 |
| Net Income Prior Year | 4,174,600,000 |
| Quarterly Revenue Growth YOY | 16.70% |
| 5-Year Revenue Growth | 6.70% |
| Operating Margin Twelve Trailing Months | 31.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 2,446,500,000 |
| Total Cash Past Year | 2,938,500,000 |
| Total Cash Prior Year | 3,045,200,000 |
| Net Cash Position Most Recent Quarter | 1,848,000,000 |
| Net Cash Position Past Year | 2,340,200,000 |
| Long Term Debt Past Year | 598,300,000 |
| Long Term Debt Prior Year | 597,700,000 |
| Total Debt Most Recent Quarter | 598,500,000 |
| Equity to Debt Ratio Past Year | 0.95 |
| Equity to Debt Ratio Most Recent Quarter | 0.95 |
| Total Stockholder Equity Past Year | 10,337,600,000 |
| Total Stockholder Equity Prior Year | 9,998,400,000 |
| Total Stockholder Equity Most Recent Quarter | 10,327,500,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,089,500,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.89 |
| Free Cash Flow Past Year | 1,335,000,000 |
| Free Cash Flow Prior Year | 289,900,000 |
Options |
|
| Put/Call Ratio | 0.07 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.87 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 6/1/2026 10:53:14 PM EST |